EASIX for prediction of survival in lower-risk myelodysplastic syndromes.
Merz A, Germing U, Kobbe G, Kaivers J, Jauch A, Radujkovic A, Hummel M, Benner A, Merz M, Dreger P, Luft T.
Merz A, et al. Among authors: kobbe g.
Blood Cancer J. 2019 Nov 11;9(11):85. doi: 10.1038/s41408-019-0247-z.
Blood Cancer J. 2019.
PMID: 31712595
Free PMC article.
Clinical Trial.